UNCY · Unicycive Therapeutics, Inc.
$5.57
+0.06 (+1.00%)
At close · Aug 17
Market Cap
$153.48M
Shares
27.86M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-11-13 | 2026-06-05 | $150,000,000 | — | — | 8-K , filed 2026-06-05 |
Key facts
CIK
1766140
CUSIP
90466Y202
13F (30d)
81 filings
79 filers
Visit website
Investor relations